Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 1
2012 3
2013 2
2015 2
2016 4
2017 8
2018 6
2019 4
2020 8
2021 4
2022 7
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Results by year

Filters applied: . Clear all
Page 1
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Lancet. 2017 Sep 16;390(10100):1211-1259. doi: 10.1016/S0140-6736(17)32154-2. Lancet. 2017. PMID: 28919117 Free PMC article.
Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study.
Leong DP, Teo KK, Rangarajan S, Lopez-Jaramillo P, Avezum A Jr, Orlandini A, Seron P, Ahmed SH, Rosengren A, Kelishadi R, Rahman O, Swaminathan S, Iqbal R, Gupta R, Lear SA, Oguz A, Yusoff K, Zatonska K, Chifamba J, Igumbor E, Mohan V, Anjana RM, Gu H, Li W, Yusuf S; Prospective Urban Rural Epidemiology (PURE) Study investigators. Leong DP, et al. Among authors: igumbor e. Lancet. 2015 Jul 18;386(9990):266-73. doi: 10.1016/S0140-6736(14)62000-6. Epub 2015 May 13. Lancet. 2015. PMID: 25982160
COVID-19 vaccine effectiveness studies in Nigeria: Quo vadis?
Akande OW, Igumbor EU, Elimian KO, Ohonsi CE, Nwozor L, Oden O, Ekpenyong EN, Ndodo N, Ike IF, Egede M, Nwachukwu W, Onoja AM, Fofah JG, Azi RI, Ochu CL, Adetifa IM. Akande OW, et al. Among authors: igumbor eu. J Glob Health. 2022 Aug 3;12:03055. doi: 10.7189/jogh.12.03055. J Glob Health. 2022. PMID: 35916589 Free PMC article. No abstract available.
Epidemiological trends of Lassa fever in Nigeria, 2018-2021.
Dalhat MM, Olayinka A, Meremikwu MM, Dan-Nwafor C, Iniobong A, Ntoimo LF, Onoh I, Mba S, Ohonsi C, Arinze C, Esu EB, Nwafor O, Oladipupo I, Onoja M, Ilori E, Okonofua F, Ochu CL, Igumbor EU, Adetifa I. Dalhat MM, et al. Among authors: igumbor eu. PLoS One. 2022 Dec 30;17(12):e0279467. doi: 10.1371/journal.pone.0279467. eCollection 2022. PLoS One. 2022. PMID: 36584167 Free PMC article.
First-line antiretroviral drug discontinuations in children.
Fortuin-de Smidt M, de Waal R, Cohen K, Technau KG, Stinson K, Maartens G, Boulle A, Igumbor EU, Davies MA. Fortuin-de Smidt M, et al. Among authors: igumbor eu. PLoS One. 2017 Feb 13;12(2):e0169762. doi: 10.1371/journal.pone.0169762. eCollection 2017. PLoS One. 2017. PMID: 28192529 Free PMC article.
55 results